Trump Administration Expands Fertility Treatment Coverage
The Trump administration has announced a deal with EMD Serono to lower drug prices as part of a larger push to expand coverage and improve affordability for fertility services.
Officials announced the plan at the White House on Thursday, outlining several key components, including:
- Lower drug prices pledged by the drugmaker
- New benefits rules to encourage employers to offer in vitro fertilization coverage outside of health insurance
- A Food and Drug Administration priority review voucher for another fertility drug not currently available in the U.S.
No direct quote available in the text.
Author's summary: Trump expands fertility treatment coverage with new deal.